Sleeping sickness: Fexinidazole receives FDA approval for treatment
by Press Release from Outbreak News Today on (#5MD2K)
By NewsDesk @infectiousdiseasenews The US Food and Drug Administration (FDA) has approved fexinidazole as the first all-oral treatment for both stages of sleeping sickness (human African trypanosomiasis). Fexinidazole was developed as part of an innovative partnership between the non-profit research and development organization Drugs for Neglected Diseases initiative (DNDi), which conducted the pivotal clinical trials for this treatment, in [...]
The post Sleeping sickness: Fexinidazole receives FDA approval for treatment appeared first on Outbreak News Today.